Deal facts
- Buyer
- MiMedx Group, Inc.
- Target
- Sanara MedTech Inc.
- Deal value
- Not disclosed
- Announced
- 1 October 2026
- Status
- In review
- Sector
- Healthcare
- Country
- United States
- Consideration
- Not stated
Deal timeline
3 updates- CMA invitation to comment
MiMedx Group, Inc. M&A filing involving Sanara MedTech Inc.
Item 8.01 Other Events. As previously announced, MiMedx Group, Inc., a Florida corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Sanara MedTech Inc., a Texas corporation (“Sanara”), and Mustang Merger Sub, Inc., a wholly-owned subsidiary of MiMedx (“Merger Subsidiary”), pursuant to which, among other things and subject to the terms and conditio
Source - CMA invitation to comment
MiMedx Group, Inc. M&A filing involving Sanara MedTech Inc.
Item 8.01 Other Events. As previously announced, Sanara MedTech Inc., a Texas corporation (the “Company” or “Sanara”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with MiMedx Group, Inc., a Florida corporation (“MiMedx”), and Mustang Merger Sub, Inc., a wholly-owned subsidiary of MiMedx (“Merger Subsidiary”), pursuant to which, among other things and subject to the terms
Source - CMA invitation to comment
MiMedx Group, Inc. M&A filing involving Sanara MedTech Inc.
Item 5.07. Submission of Matters to a Vote of Security Holders Results of Special Meeting On September 30, 2026, Sanara MedTech Inc., a Texas corporation ( “Sanara”), held a special meeting of shareholders (the “Special Meeting”) to vote on the proposals described in Sanara’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on September 4, 2026 (the “Proxy Statemen
Source
For business owners
What would selling your own business involve?
Use the deal as a starting point, not a valuation benchmark. Learn the decisions behind a sale and apply them to your own preparation.
Guides are free to read. Free tools require email access; indicative results are not professional advice.
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Circle Health Holdings Limited to acquire CHC Healthcare Holdings Limited
Circle Health Holdings Limited has agreed to acquire CHC Healthcare Holdings Limited in a strategic acquisition within the healthcare sector. Both entities are based in…
- Buyer
- Circle Health Holdings Limited
- Target
- CHC Healthcare Holdings Limited
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
BioAdaptives, Inc. to acquire Xycota Biosciences LLC
BioAdaptives, Inc. entered into a definitive Membership Interest Purchase Agreement on October 29, 2026 to acquire 100% of the issued and outstanding membership interest…
- Buyer
- BioAdaptives, Inc.
- Target
- Xycota Biosciences LLC
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Ayrmid Ltd. to acquire Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc. and its subsidiary KPT Texas LLC filed voluntary Chapter 11 petitions on November 2, 2026 in the U.S. Bankruptcy Court for the Southern Dist…
- Buyer
- Ayrmid Ltd.
- Target
- Karyopharm Therapeutics Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Azenta, Inc. to acquire SynPlexity Inc.
Azenta, Inc. acquired SynPlexity Inc. on October 28, 2026, by entering into a Stock Purchase Agreement with SynPlexity, its stockholders and other parties. Under the agr…
- Buyer
- Azenta, Inc.
- Target
- SynPlexity Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Pelthos Therapeutics Inc. to acquire Castle Creek Biosciences, Inc.
Pelthos Therapeutics Inc. signed an Agreement and Plan of Merger on October 30, 2026 to acquire Castle Creek Biosciences, Inc., according to Pelthos's Form 8-K of that d…
- Buyer
- Pelthos Therapeutics Inc.
- Target
- Castle Creek Biosciences, Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Buyer history
MiMedx Group, Inc.
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive